| 000 | 01281nam a2200265 4500 | ||
|---|---|---|---|
| 001 | 7403 | ||
| 010 | _a9291680613 | ||
| 090 | _a7403 | ||
| 100 | _a20011112d1999 y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aGuidelines for the risk assessment of new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction |
||
| 210 |
_aLuxembourg _cOffice for Official Publications of the European Communities _d1999 |
||
| 215 |
_a33 p. _d21 cm |
||
| 330 | _aBasic principles for risk assessment. A conceptual framework for risk assessment. Quality of information for risk assessment. Headings for risk assessment. Pharmacotoxicological evidence. Psychological risk assessment (cognition, mood and mental functioning). Sociological/criminological evidence. Public health risks: epidemiological evidence. | ||
| 606 |
_aSAÚDE PÚBLICA _91370 |
||
| 606 |
_aCONSUMO DE DROGA _95102 |
||
| 606 |
_aUNIÃO EUROPEIA _9100 |
||
| 710 |
_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA _95764 |
||
| 852 | _jDRO221 | ||